Commonwealth Fund: ACA’s medical loss ratio rule saves $5 billion
The Affordable Care Act’s requirement that health insurers pay out a minimum percentage of premiums in medical claims... More
Senate recesses without addressing SGR repeal bill
The Senate adjourned for a 2-week recess early on March 27, leaving without taking action on House-passed legislation... More
Rep. Michael C. Burgess
Physicians are lauding passage of legislation by the House of Representatives to repeal the Medicare Sustainable Growth... More
Dr. Susan Rose
SAN DIEGO – Remain vigilant for endocrine side effects after reduced-intensity conditioning for hematopoietic stem cell... More
CMS: All docs, hospitals must be on Stage 3 meaningful use in 2018
All physicians and hospitals would need to be meet stage 3 meaningful use beginning in 2018, according to a recent... More
Medicare advisers: Cancer prognostic tests not ready for prime time
BALTIMORE – While prognostic tests tied to specific chemotherapy agents may offer a clear benefit in guiding treatment... More
VIDEO: Sun protection urged for Asian, Hispanic women
SAN FRANCISCO – Among Asian and Hispanic patients, women are more likely than men are to get nonmelanoma skin cancer,... More
HHS Secretary Sylvia M. Burwell
The federal government has launched the Health Care Payment Learning and Action Network as a way to help physicians and... More
Rep. Fred Upton
Bipartisan lawmakers have introduced a bill that would repeal the Medicare Sustainable Growth Rate (SGR) formula, this... More
Dr. David F. McDermott
After a median follow-up of 45 months, the anti–PD-1 antibody nivolumab showed benefit in a majority of patients who... More
Dr. Mark W. Friedberg
WASHINGTON– Are physicians ready for the shift toward value-based compensation? A report from the American Medical... More
FAQ: What’s in the House proposal to fix the SGR?
It’s make-or-break time for a Medicare “doc fix” replacement. The House is likely to vote the week of March 23 on a... More

News

SHARON WORCESTER
BIRMINGHAM, ALA. – Determining whether patients prefer colonoscopy or a stool sample blood test for colorectal cancer screening, and then providing support for completing the preferred method, could increase screening rates and reduce racial dispar... More »
 

News, Health Reform

GREGORY TWACHTMAN
The Affordable Care Act’s requirement that health insurers pay out a minimum percentage of premiums in medical claims or quality improvement generated $5 billion in savings from 2011 to 2013, according to the Commonwealth Fund. However, insurance... More »
 

Practice Economics

GREGORY TWACHTMAN
The Affordable Care Act’s requirement that health insurers pay out a minimum percentage of premiums in medical claims or quality improvement generated $5 billion in savings from 2011 to 2013, according to the Commonwealth Fund. However, insurance... More »
 

Reimbursement and Management

DENISE FULTON
The Senate adjourned for a 2-week recess early on March 27, leaving without taking action on House-passed legislation to repeal the Medicare Sustainable Growth Rate formula and reauthorize the Children’s Health Insurance Program. The Senate will n... More »
 

Commentaries

Yes: Both patients and science can benefit from genomic analysis of tumors. Use of molecular profiling of gastrointestinal tumors is ready for prime time. My contention is that both patients and science can benefit from genomic analysis of tumors. ... More »
 

Commentaries

JEFFREY BENABIO, M.D.
Doctors have been conjecturing about how the new Apple Watch, with its spectacular fitness and wellness tracking features, will transform health care. The real rock star at Apple’s March 9 “Spring Forward” event, however, was the opening band, ... More »
 
RENEE MATTHEWS
SAN ANTONIO – In a roundtable at the 2014 San Antonio Breast Cancer Symposium, Dr. Jame Abraham, Dr. Linda Bosserman, and Dr. Debra Patt discussed their top selections from the meeting’s presentations. Among the topics were the promising findin... More »
 
Yes: Both patients and science can benefit from genomic analysis of tumors. Use of molecular profiling of gastrointestinal tumors is ready for prime time. My contention is that both patients and science can benefit from genomic analysis of tumors. ... More »